United States patent law

Retrocausal Raises Oversubscribed $5.3M Round to Meet Increased Demand for its Generative AI Manufacturing Assembly Optimization Solution

Retrieved on:

Thursday, November 30, 2023

Workforce, First officer (aviation), Ff Venture Capital, National Association, FTY, HVAC, Innovation, United States patent law, 3D printing

Funding will be used to meet the increased market demand for its proprietary generative AI technology, Retrocausal’s Kaizen Copilot software for Manufacturing Assembly Optimization .

Key Points:

Funding will be used to meet the increased market demand for its proprietary generative AI technology, Retrocausal’s Kaizen Copilot software for Manufacturing Assembly Optimization .
Retrocausal’s solution simplifies manual assembly operations and the underlying processes to empower the low-skilled workforce to take on high-skill manufacturing jobs.
Retrocausal’s industry-first solution is addressing the acute labor crisis in manufacturing.
Manufacturing now makes up just over 8% of the U.S. workforce, about half of early 1990s levels, the lowest share ever.

AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents

Retrieved on:

Tuesday, November 28, 2023

OCALA, Fla., Nov. 28, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. patent No. 11,813,279 and 11,813,281 for Ampligen® titled “Compositions for cancer therapy and methods,” and “Methods for improving exercise tolerance in myalgic encephalomyelitis patients,” respectively.

Key Points:

11,813,279 and 11,813,281 for Ampligen® titled “Compositions for cancer therapy and methods,” and “Methods for improving exercise tolerance in myalgic encephalomyelitis patients,” respectively.
AIM Chief Executive Officer Thomas K. Equels stated: “Our ongoing effort to expand and solidify AIM’s global intellectual property estate is a foundational component of our development strategy for Ampligen.
The combination of these compounds is designed to work synergistically to enhance the effectiveness of the treatment.
This exclusivity fortifies AIM's position in the market by enabling development of a distinctive and unparalleled treatment option.

AIM ImmunoTech Bolsters Intellectual Property Estate for Ampligen® with Issuance of Two Key U.S. Patents

Retrieved on:

Monday, November 27, 2023

OCALA, Fla., Nov. 27, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. patent No. 11,813,279 and 11,813,281 for Ampligen® titled “Compositions for cancer therapy and methods,” and “Methods for improving exercise tolerance in myalgic encephalomyelitis patients,” respectively.

Key Points:

11,813,279 and 11,813,281 for Ampligen® titled “Compositions for cancer therapy and methods,” and “Methods for improving exercise tolerance in myalgic encephalomyelitis patients,” respectively.
AIM Chief Executive Officer Thomas K. Equels stated: “Our ongoing effort to expand and solidify AIM’s global intellectual property estate is a foundational component of our development strategy for Ampligen.
The combination of these compounds is designed to work synergistically to enhance the effectiveness of the treatment.
This exclusivity fortifies AIM's position in the market by enabling development of a distinctive and unparalleled treatment option.

STMicroelectronics releases long-range wireless microcontrollers for energy-efficient connectivity in smart metering, smart building, and industrial monitoring

Retrieved on:

Monday, November 20, 2023

ASK, NYSE, Engineering, RF, STM, MCU, KNX, ADC, Electronics, Radio, OOK, Multi, ISM, MSK, BOM, RAM, SMPS, DAC, DSSS, Communication, STMicroelectronics, United States patent law, Patent, LCD, Family, STM32, DBPSK, Temperature, FSK, Architecture, Mobile phone, Consumer electronics, Video game

Device and application designers can leverage ST’s wireless MCUs to develop and deliver new products to the world quickly for maximum benefit.

Key Points:

Device and application designers can leverage ST’s wireless MCUs to develop and deliver new products to the world quickly for maximum benefit.
For example, Lierda Internet of Things Technology, is using the STM32WL33 to reduce power and add long range wireless connectivity to existing networking products.
Another customer, Silent Smart Technology, has created a family of modules based on STM32WL3 wireless MCUs that operate in various sub-1GHz frequency bands.
STM32 is a registered and/or unregistered trademark of STMicroelectronics International NV or its affiliates in the EU and/or elsewhere.

Dragonfly Energy Reports Third Quarter 2023 Financial and Operational Results

Retrieved on:

Monday, November 13, 2023

As expected, this had a material adverse impact on our OEM sales in the third quarter of 2023.

Key Points:

As expected, this had a material adverse impact on our OEM sales in the third quarter of 2023.
Third quarter 2023 Gross Profit was $4.6 million, compared to $7.0 million in the third quarter of 2022.
Third quarter 2023 EBITDA was $(5.7) million, compared to EBITDA of $(3.1) million in the third quarter of 2022.
Dragonfly Energy retains strong financial flexibility with access to a largely undrawn $150 million equity line of credit.

RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs

Retrieved on:

Thursday, November 9, 2023

PETALUMA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today announced that it has submitted two provisional patent applications to the US Patent Office for its investigational therapeutic drug candidates RTG-2023 and RTG-2024.

Key Points:

PETALUMA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today announced that it has submitted two provisional patent applications to the US Patent Office for its investigational therapeutic drug candidates RTG-2023 and RTG-2024.
There are two forms of the disease; wet AMD and dry AMD.
ADI estimates there are over 10 million new cases of dementia each year worldwide, implying one new case every 3.2 seconds.
The Company’s novel approach includes the use of high-resolution retinal imaging and pharmacogenetic mapping to be combined with the promise of these investigational drugs.

USPTO Issues Final Rejection of Magnolia Medical’s ‘483 Patent at Issue in Litigation

Retrieved on:

Wednesday, December 6, 2023

Professional Services, Health, Legal, General Health, Pharmaceutical, Biotechnology, Kurin, Examiner, Patient, Infection, United States patent law, Patent, Confusion

Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced today that the US Patent and Trademark Office has issued a Final Rejection in its reexamination of claims 1 and 24 of U.S. Patent No.

Key Points:

Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced today that the US Patent and Trademark Office has issued a Final Rejection in its reexamination of claims 1 and 24 of U.S. Patent No.
10,039,483 (the ‘483 patent).
Claims 1 and 24 of the ‘483 patent were asserted by Magnolia Medical against Kurin’s Lock product in a patent infringement case in Delaware Federal Court.
The USPTO Examiner has rejected Magnolia’s arguments regarding patentability, and the pertinent claims of that patent now stand as rejected.

Hayden AI Granted Patent for Traffic Violation Evidence Review System

Retrieved on:

Thursday, November 30, 2023

Technology, Other Technology, Transportation, Audio, Video, Software, Artificial Intelligence, Travel, Intelligence, City, United States patent law, Public sector, Safety, Algorithm, Patent, Mobile phone, AI

Hayden AI, a global leader in artificial intelligence and geospatial analytics, has been awarded a patent for its system for automatically validating video evidence of traffic violations, enabling cities to enforce dangerous traffic violations at scale.

Key Points:

Hayden AI, a global leader in artificial intelligence and geospatial analytics, has been awarded a patent for its system for automatically validating video evidence of traffic violations, enabling cities to enforce dangerous traffic violations at scale.
The patent was awarded on October 3, 2023 and is labeled US Patent number 11,776,276, B1.
Hayden AI’s mobile perception platform utilizes computer vision and deep learning technology that automatically detects context features to determine if a traffic violation occurred in video evidence.
By inputting video frames of a potential traffic violation into a deep learning algorithm, Hayden AI’s solution “scores” each evidence package to identify difficult cases.

Mitel Appoints Luiz Domingos as Chief Technology Officer

Retrieved on:

Wednesday, November 29, 2023

Mitel® , a global leader in business communications, today announced that Luiz Domingos has been named Chief Technology Officer (CTO) and Head of Large Enterprise R&D.

Key Points:

Mitel® , a global leader in business communications, today announced that Luiz Domingos has been named Chief Technology Officer (CTO) and Head of Large Enterprise R&D.
View the full release here: https://www.businesswire.com/news/home/20231129568175/en/
Luiz Domingos, Chief Technology Officer (CTO) and Head of Large Enterprise R&D at Mitel.
During his tenure at Unify, he served as Chief Product and Technology Officer, managing the complete portfolio and developing disruptive cloud solutions.
“I am thrilled and honored to take on this role, especially during such a significant time at Mitel," said Domingos.

Cobalt Iron Secures Patent on Applying Machine Learning to Cyber Inspection

Retrieved on:

Thursday, November 16, 2023

Data Management, Security, Technology, Software, Networks, Artificial Intelligence, Internet, Machine learning, Risk, Patent, United States patent law, Software as a service, Risk management, Arms industry, Maintenance (technical), Compass

Cobalt Iron Inc. today announced that it has received another new patent, this time for machine learning-driven cyber inspection.

Key Points:

Cobalt Iron Inc. today announced that it has received another new patent, this time for machine learning-driven cyber inspection.
Automatic adjustment of policy-driven cyber inspection using multiple cyber inspection tools and multiple cyber inspection levels:
at different times or events in the life cycle of a data object.
In another instance, the technology might enable Compass to analyze machine learning training data from previous cyber attacks and previous cyber inspection operations to determine whether a different cyber inspection tool or a different level of inspection would be more effective at detecting particular types of cyber attack patterns.
And if so, it may dynamically adjust the cyber inspection tool or level of inspection it performs against particular types of data in future cyber inspection operations.